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Background & aims: Arachidonic (AA) and eicosapentaenoic (EPA)
polyunsaturated fatty acids can play respectively a pro- and an
anti-inﬂammatory role. We hypothesized that, at the end of 5-
week experimental bed rest, baseline AA/EPA in red blood cells
(RBC) membranes, considered the result of dietary fat intake over
the previous month, could inﬂuence lean body mass wasting in
twenty-six healthy volunteers (age: 23.5 ± 0.5 years; body mass
index: 22.9 ± 0.5 kg/m2).
Methods: We measured AA and EPA content in RBC membranes at
baseline ambulatory conditions and at the end of the study pro-
tocol, to verify the PUFA concentrations stability. We assessed
changes, between beginning and end of bed, in lean body mass
(bioimpedance), insulin resistance (homeostasis model assess-
ment), systemic inﬂammation (C-reactive protein) and oxidative
stress (thiobarbituric acid reactive substances). Volunteers were
divided in two groups according to the AA/EPA ratio median value
(i.e. AA/EPA ¼ 44): High AA/EPA group (60 ± 3; n ¼ 13) and Low
AA/EPA group (37 ± 1; n ¼ 13).
Results: At baseline, all analyzed anthropometrical and biochem-
ical indices were similar in the two groups. Bed rest induced a
major decrease in lean body mass in High AA/EPA group
(5.2 ± 0.5%), when compared to Low AA/EPA group (3.7 ± 0.5%;
p ¼ 0.03; ANOVA). Bed rest mediated-changes of insulin resistance,
fat mass, systemic inﬂammation and oxidative stress, failed toHospital, Strada di Fiume 447, 34149 Trieste, Italy. Tel.: þ39 040 399 4532;
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pooled data, baseline AA/EPA ratio and percent lean body mass
delta changes showed a signiﬁcant inverse correlation (n ¼ 26;
R ¼ 0.50; p < 0.01).
Conclusions: Results suggest that baseline AA/EPA, in RBC mem-
branes, can independently predict lean body mass wasting in
immobilized subjects during long term disuse.
© 2017 The Authors. Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sarcopenia affects quality of life and outcome in elderly subjects and in chronically ill patients [1].
Reliable clinical markers able to predict the level of muscle atrophy progression are presently lacking.
Physical inactivity and inﬂammatory response are key factors inducing muscle wasting in different
conditions [2]. Inﬂammation, in particular, is known to trigger muscle wasting in many acute and
chronic diseases, as well as during aging and physical inactivity [3,4]. Onset, progression and ampli-
ﬁcation of inﬂammatory response rely on metabolites derived either from the proinﬂammatory n-6
polyunsaturated fatty acid (PUFA) (arachidonic acid, AA), or from the anti-inﬂammatory n-3 PUFA
(docosahexaenoic acid and eicosapentaenoic acid, EPA) [5]. Therefore, the ratio between n-3 PUFA and
n-6 PUFA is considered to inﬂuence the inﬂammatory response, in several clinical conditions [6]. An
elevated availability of n-6 PUFA in cell membrane has been shown to correlate to inﬂammatory
diseases [6] and to activation of Nuclear Factor-Kappa B, a transcriptional factor controlling protein
degradation, through the proteasome-system [7]. On the other side, EPA is known to efﬁciently inhibit
eicosanoids production, thus reducing inﬂammation and its consequences [8]. PUFA availability and
type depends is diet-dependent [9]. Some dietary fats, such as vegetable oils and margarines, contain
elevate fractions of n-6 PUFA, while foods such as fatty ﬁsh, ﬁsh oil and nuts are sources of n-3 PUFA [9].
Recently it has been suggested that n-3 PUFA can improve the protein anabolism in many physiological
and pathological conditions [10]. We hypothesized that skeletal muscle catabolism, induced by inac-
tivity or by other conditions associated with sarcopenia, could also be inﬂuenced by the AA/EPA ratio.
Experimental bed rest is a suitable model to investigate muscle atrophy progression in controlled
conditions [11e13]. We measured the body composition changes (bioimpedance analysis) in healthy
volunteers before and after 35 days of experimental bed rest and compared them to the AA/EPA ratios,
measured on red blood cells (RBC) membranes. Diet composition of the month before the study
protocol, assessed in each subject at enrollment, was maintained throughout the study. Insulin
resistance (homeostasis model assessment, HOMA), systemic inﬂammation (high sensible C-reactive
protein, high-CRP) and oxidative stress (thiobarbituric acid reactive substances, TBARS) were also
investigated.
2. Methods
Thirty healthy young male volunteers were enrolled to participate to three separated 35-day bed
rest studies, each including 10 participants. The experiments were conducted at the Valdoltra Hospital
(University of Primorska, Ankaran-Capodistria, Slovenia) in the periods of JulyeAugust 2006, 2007 and
2008. The project was approved by the ethical committee of the University of Ljubljana and the
experimental protocol is in accordance to the Declaration of Helsinki and its amendments (2002). A
written informed consent was obtained by each volunteer upon enrollment. All subjects were physi-
cally active before admission to the hospital, none of them was under medication and their body
weight and diets had been stable during the previous month.
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The experimental design is fully described elsewhere [14,15]. Brieﬂy, volunteers were admitted at
the hospital one week before the bed rest period to allow a dietary and environmental adaptation
(ambulatory period). At this time, baseline standard anthropometric measures (body weight and
height) and routine medical examinations were performed. Individual dietary habits, relative to the
previous month, were assessed through a suitable food frequency questionnaire, while habitual
portion sizes were evaluated by a dietitian through household items and a food picture atlas. At the end
of the ambulatory period, each subject underwent 35 days of strict bed rest, a model of experimental
immobilization during which all daily activities are performed in clinostatic conditions. All volunteers
were under frequent periodical medical control and constant nursing assistance. During both ambu-
latory and bed rest periods, three main meals (breakfast, lunch and dinner) and three snacks were
served. To allow the maintenance, during the experimental study, of a diet equivalent to the habitual
one, the dietitian prepared speciﬁc menus for each subjects, including condiments and fat food cate-
gories. Furthermore, the actual food intake at each meal was monitored by the dietitian. Body
composition changes (i.e. fat mass, FM and lean body mass, LBM) were assessed by multifrequency
bioelectrical impedance (BIA, Human IM Plus; DS Dietosystem, Milan, Italy) before, during, and after
the experimental period. A blood sample (5 mL) was collected in the post-absorptive state before and
after bed rest (EDTA Tubes, BD Vacutainer, NJ, USA).
2.2. Biochemical analysis
Red blood cells membrane PUFA composition was measured at baseline ambulatory conditions and
at the end of the study protocol, to conﬁrm the expected PUFA concentrations stability form the careful
dietary control, as previously published [15]. Brieﬂy, fatty acids were extracted from erythrocytes, after
cell lysis, by repeated washing with hypotonic solutions and treatment with chloroform-methanol.
Methyl-esteriﬁcation of fatty acids was obtained in a methanol solution containing H2SO4. After
neutralization, methyl-esters were extracted and resuspended in hexane. Analysis was carried out by
gas-chromatographyeﬂame ionization detection (GC-FID; GC 6850 Agilent Technologies, Santa Clara,
CA, USA). AA and EPA contents were expressed as percent ratio between area under-the-curve of each
selected methyl-ester peak and the sum of all measured methyl-ester peaks. High-CRP was measured
with standard methods by a certiﬁed external laboratory (Synlab Italia Srl, Italy). TBARS, as index of
lipid peroxidation in plasma, was determined using a commercially available kit (Oxitek, ZeptoMetrix
Co., Buffalo, NY, USA) with slight modiﬁcations, as previously reported [14].
2.3. Data presentation and statistics
Volunteerswere stratiﬁed according to theAA/EPA ratio assessed at baseline. Subjectswith anAA/EPA
ratio above the median value were identiﬁed as High AA/EPA group, while subjects with lower values
were assigned to the Low AA/EPA group. Data are expressed as median values and interquartile range
(IQR) reported in parenthesis. Data were log-transformed where appropriate. The differences between
the two groups (High-AA/EPA and Low-AA/EPA) were evaluated through the ManneWhitney non-
parametric test for independent samples. The effect of bed rest on analyzed parameters in the two
groups, was assessed by repeated measures ANOVA, with activity (baseline and bed rest) as within-
subject factor and groups (Low and High AA/EPA groups) as between-subject factor. Statistical signiﬁ-
cance of correlation analysis was assessed by Spearman's test. p  0.05 was considered statistically sig-
niﬁcant. Statistical analysis was performed using SPSS software (version 12; SPSS, Inc., Chicago, IL, USA).
3. Results
All participants concluded the bed rest period, although four were excluded from analysis: Two
subjects were excluded for technical problems in the assessment of baseline erythrocyte membrane
composition and two because deﬁned as outliers considering their fat mass gain during bed rest
(>2 kg). The remaining volunteers (age: 24.0 yrs IQR 23e25; body mass index, BMI: 23.2 kg/m2 IQR
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ratio above the median value (i.e. AA/EPA¼ 44) were identiﬁed as High-AA/EPA group (57, IQR 51e68),
while subjects with lower values were assigned to the Low-AA/EPA group (38, IQR 33e41). No sig-
niﬁcant difference was found in AA/EPA ratio, assessed before and after 35 days of bed rest, within and
between subjects (p > 0.05). Baseline AA content in the High (18%, IQR 16e18) and Low (17%, IQR
15e18) AA/EPA groups was not signiﬁcantly different (p ¼ 0.43), while baseline EPA content in the
High-AA/EPA group (0.32, IQR 0.27e0.36) was signiﬁcantly lower than in the Low-AA/EPA group (0.47,
IQR 0.36e0.52) (p < 0.015). Body weight, height and composition (FM and FFM) were not different, at
baseline, between High and Low AA/EPA groups (Table 1). A signiﬁcant bed rest effect in decreasing
lean body mass was shown (Table 2). As evidenced by the signiﬁcant group  bed rest interaction, bed
rest induced a major decrease of lean body mass in the High AA/EPA group when compared to Low AA/
EPA group [5.2% (6.9 to 4) and 3.9% (5.3 to 2.8) respectively, p ¼ 0.03, non-parametric
ManneWhitney test] (Table 2). Bed rest signiﬁcantly increased fat mass and HOMA index, however
no group  bed rest interaction was demonstrated. Neither bed rest effect nor group  bed rest
interaction is demonstrated for TBARS or high-CRP plasma concentrations (Table 2). Baseline AA/EPA
ratio and percent lean body mass changes, mediated by bed rest, in pooled subjects showed a signif-
icant inverse correlation (Fig. 1).
4. Discussion
Markers able to predict muscle atrophy following long term exposure to stressors such as physical
inactivity, are lacking. We evaluated 26 volunteers enrolled in three bed rest studies (Valdoltra bed rest
2006, 2007 and 2008) [14e16]. The present work was aimed to investigate in healthy volunteers, the
associations between change in lean body mass after 5 weeks of inactivity and the AA/EPA ratio in
erythrocytemembranes at baseline. This allowed us to identify a group of subjects with an AA/EPA ratio
higher (High AA/EPA) or lower than the median value (Low AA/EPA) than the median value (i.e. AA/
EPA¼ 44). The signiﬁcant difference of mean AA/EPAvalues between the two groups reﬂects variability
in previous dietary fat intake. Lean body mass wasting in the High AA/EPA group was markedly and
signiﬁcantly greater when compared to the Low AA/EPA group (Table 2), suggesting that dietary fat
intake with a lower n-6 AA/n-3 EPA ratio, before a period of inactivity can worsen atrophy progression
in the unloaded muscles. These results are conﬁrmed by the signiﬁcant linear correlation between
baseline AA/EPA ratio, in RBC membranes, and lean body mass wasting, in pooled subject data (Fig. 1).
This correlation does not seem to be inﬂuenced by other factors potentially related to lean body mass
wasting, such as changes in energy balance, insulin resistance [16] and whole body stress response
[14]. Our results are in perfect agreement with a previous publication which showed that cancer pa-
tients with a lower baseline EPA availability had a greater muscle mass wasting, following chemo-
therapy treatment [17]. Even though additional studies are needed, our results, and previously
published evidences [17], suggest that baseline AA/EPA in RBC membranes can be considered a po-
tential predictive marker of muscle atrophy after a catabolic period. In the present work we can hy-
pothesize that baseline fatty acid membrane composition could affect lean body mass wasting, during
inactivity, by a modulation of the inﬂammatory response, mediated by PUFA families [18]. Inﬂam-
mation is known to contribute to muscle atrophy [18]. Studies performed in animal models showedTable 1
Volunteers characteristics.
Low AA/EPA group High AA/EPA group p
Body weight (kg) 73 (70e77) 77 (73e85) 0.17
Height (cm) 183 (175e185) 181 (172e182) 0.20
LMB (kg) 61 (59e64) 64 (61e67) 0.69
FM (kg) 10 (9e12) 12 (11e14) 0.22
LMB, lean body mass; FM, fat mass. Data are expressed as median values and in parenthesis interquartile range. Data were log-
transformed where appropriate. Volunteers were stratiﬁed accordingly to AA/EPA ratio assessed at baseline. Subjects showing
an AA/EPA ratio higher than the median value (i.e. AA/EPA ¼ 44) were identiﬁed as High AA/EPA group, while subjects with
lower values were assigned to the Low AA/EPA group. The differences between the two groups (High-AA/EPA and Low-AA/EPA)
were evaluated through the ManneWhitney non-parametric test for independent samples.
Table 2
Body composition changes induced by bed rest in low AA/EPA and in high AA/EPA groups.
Low AA/EPA group High AA/EPA group p
Baseline Day 35 Baseline Day 35 Bed rest
effect
Group  bed
rest interaction
LMB (kg) 61 (59e64) 59 (58e62) 64 (61e67) 61 (56e64) <0.001 0.03
FM (kg) 10 (9e12) 11 (8e13) 12 (11e14) 13 (11e15) 0.001 0.16
HOMA index 1.2 (0.8e1.5) 1.3 (1.1e1.7) 1.1 (0.9e1.6) 2.1 (1.3e3.3) <0.001 0.25
TBARS (mmol/L) 1.7 (1.4e2.4) 1.5 (0.7e5.4) 1.5 (1.0e2.5) 2.0 (1.3e3.2) 0.11 0.65
High-CRP (mg/L) 0.04 (0.02e0.07) 0.03 (0.01e0.08) 0.07 (0.02e0.17) 0.05 (0.01e0.14) 0.60 0.30
LMB, lean bodymass; FM, fat mass; HOMA, homeostatic model assessment of insulin resistance index; TBARS, thiobarbituric acid
reactive substances; high-CRP, high-C-reactive protein. The table shows values at baseline and after bed rest (Day 33). Data are
expressed as median values and in parenthesis interquartile range. Data were log-transformed where appropriate. Volunteers
were stratiﬁed accordingly to AA/EPA ratio assessed at baseline. Subjects showing an AA/EPA ratio higher than the median value
(i.e. AA/EPA ¼ 44) were identiﬁed as High AA/EPA group, while subjects with lower values were assigned to the Low AA/EPA
group. Statistical analysis was performed by analysis of variance (ANOVA) with activity (baseline and bed rest) as within-subject
factor and group (Low and High AA/EPA groups) as between-subject factor.
Fig. 1. Correlation between percent lean body mass changes mediated by inactivity and baseline AA/EPA in cell membranes. It shows
the signiﬁcant linear inverse correlation between percent changes of lean body mass induced by 5 weeks of bed rest and absolute
values of arachidonic to eicosapentaenoic acid ratio measured at baseline in erythrocyte membranes (baseline AA/EPA). Statistical
signiﬁcance was assessed by Spearman's test for analysis of correlations.
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dependent proteolytic pathways [19], while higher AA availability accelerates protein turnover [20].
In conclusion, we demonstrated in humans that baseline AA/EPA can predict the extent in lean body
mass wasting after a long term immobilization. We suggest that, lowering AA/EPA by a higher EPA
dietary intake, before and during a period of inactivity could blunt lean body mass wasting induced by
unloading.
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